• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.

作者信息

Liu Tsu-Te, Wong Wen-Jang, Hou Ming-Chih, Lin Han-Chieh, Chang Full-Young, Lee Shou-Dong

机构信息

Division of Gastroenterology, Department of Medicine, Taipei-Veterans General Hospital and the National Yang Ming University School of Medicine, Taipei, Taiwan.

出版信息

J Gastroenterol Hepatol. 2006 May;21(5):908-13. doi: 10.1111/j.1440-1746.2006.04266.x.

DOI:10.1111/j.1440-1746.2006.04266.x
PMID:16704544
Abstract

BACKGROUND

Patients with decreased blood viscosity are supposed to have a higher risk of bleeding and increased severity of bleeding (severity of bleeding proportional to transmural pressure x area of variceal tear/blood viscosity). However, the hemorheological factors have never been assessed in patients with esophageal variceal bleeding. Therefore, the purpose of the present study was to examine the hemorheological factors in liver cirrhotic patients with special emphasis on the outcome of variceal bleeding.

METHODS

Forty-two liver cirrhosis patients with variceal bleeding and another 44 matched patients without bleeding were enrolled. The hemorheological and hemostatic factors of their peripheral blood were examined. The clinical course was under careful surveillance.

RESULTS

Patients with poor hepatic reserve (Child B + C vs A) had lower whole blood viscosity (4.34 +/- 0.56 mPa.s vs 5.06 +/- 1.35 mPa.s, P < 0.05), lower hematocrit levels (32.86 +/- 5.97% vs 36.62 +/- 5.44%, P < 0.05), lower platelet counts (79.7 +/- 47.6 x 10(3)/mL vs 108.0 +/- 71.2 x 10(3)/mL, P < 0.05) and prolonged prothrombin time (2.88 +/- 2.33 s vs 1.27 +/- 1.37 s, P < 0.05). Patients with bleeding (vs non-bleeding group) had lower hematocrit levels (31.44 +/- 5.75% vs 36.57 +/- 5.19%, P < 0.01) and lower fibrinogen levels (226.7 +/- 92.7 mg/dL vs 286.4 +/- 111.8 mg/dL, P < 0.05). Patients with bleeding with shock had worse liver cirrhosis (Child A/B/C = 0/5/4 vs 11/18/4, P < 0.05), lower whole blood viscosity (4.01 +/- 0.17 mPa.s vs 4.57 +/- 0.76 mPa.s, P < 0.05), reduced erythrocyte aggregability (2.94 +/- 0.41 vs 3.54 +/- 0.61, P < 0.001), and lower platelet counts (56.22 +/- 17.05 x 10(3)/mL vs 88.87 +/- 38.12 x 10(3)/mL, P < 0.001). The Child-Pugh grade and erythrocyte aggregability were two independent factors associated with bleeding shock.

CONCLUSIONS

Whole blood viscosity, hematocrit levels and platelet counts were lower in patients with advanced liver cirrhosis. Advanced liver cirrhosis and reduced erythrocyte aggregability were independent factors for hypovolemic shock in cirrhotic patients with esophageal variceal bleeding. However, the causal relationship between hemorheology and bleeding needs to be clarified in further studies.

摘要

相似文献

1
Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding.
J Gastroenterol Hepatol. 2006 May;21(5):908-13. doi: 10.1111/j.1440-1746.2006.04266.x.
2
Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.近年来肝硬化合并食管静脉曲张患者静脉曲张出血的临床意义。
J Gastroenterol Hepatol. 2004 Sep;19(9):1042-51. doi: 10.1111/j.1440-1746.2004.03383.x.
3
Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index.肝硬化患者首次静脉曲张出血风险的预后指标:一项针对711例患者的多中心研究,旨在验证和改进意大利北部内镜俱乐部(NIEC)指数。
Am J Gastroenterol. 2000 Oct;95(10):2915-20. doi: 10.1111/j.1572-0241.2000.03204.x.
4
MELD score, child-pugh score, and decreased albumin as risk factors for gastric variceal bleeding.终末期肝病模型(MELD)评分、Child-Pugh评分以及白蛋白降低作为胃静脉曲张出血的危险因素。
Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1552-6.
5
[Primary risk of hemorrhage due to esophageal varices in cirrhotic patients: significance of the associated endoscopic signs and hepatic functional reserve].[肝硬化患者食管静脉曲张出血的主要风险:相关内镜征象及肝功能储备的意义]
Acta Gastroenterol Latinoam. 1991;21(2):107-13.
6
Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis.肝硬化合并食管或胃静脉曲张出血患者的预后:多因素分析
Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):416-9.
7
Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage.
Hepatology. 1991 Mar;13(3):407-12.
8
Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.特利加压素与奥曲肽用于内镜下套扎术辅助治疗出血性食管静脉曲张:一项随机双盲安慰剂对照试验
Am J Gastroenterol. 2009 Mar;104(3):617-23. doi: 10.1038/ajg.2008.147. Epub 2009 Feb 17.
9
[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].[韩国肝硬化患者肝静脉压力梯度的测量:与肝硬化状态、静脉曲张及腹水的关系]
Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150.
10
[Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].静脉用环丙沙星预防肝硬化食管静脉曲张出血患者细菌感染的前瞻性随机试验
Taehan Kan Hakhoe Chi. 2002 Sep;8(3):288-96.

引用本文的文献

1
CT-based nomogram predicts esophageal gastric variceal bleeding in noncirrhotic portal hypertension caused by hepatic schistosomiasis.基于CT的列线图可预测肝血吸虫病所致非肝硬化门静脉高压症患者食管胃静脉曲张出血情况。
BMC Med Inform Decis Mak. 2025 Jan 7;25(1):8. doi: 10.1186/s12911-024-02777-9.
2
Application of machine learning methods for predicting esophageal variceal bleeding in patients with cirrhosis.机器学习方法在预测肝硬化患者食管静脉曲张出血中的应用。
Eur Radiol. 2025 Mar;35(3):1440-1450. doi: 10.1007/s00330-024-11311-4. Epub 2024 Dec 21.
3
One in four patients with gastrointestinal bleeding develops shock or hemodynamic instability: A systematic review and meta-analysis.
四分之一的胃肠道出血患者会出现休克或血流动力学不稳定:系统评价和荟萃分析。
World J Gastroenterol. 2023 Jul 28;29(28):4466-4480. doi: 10.3748/wjg.v29.i28.4466.
4
Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients.基于机器学习的模型预测肝硬化患者胃食管静脉曲张出血风险。
Diagn Pathol. 2023 Feb 23;18(1):29. doi: 10.1186/s13000-023-01293-0.
5
A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis.一种用于预测 HBV 相关肝硬化患者首次静脉曲张出血风险的新型预后模型。
Front Cell Infect Microbiol. 2023 Jan 17;13:1062172. doi: 10.3389/fcimb.2023.1062172. eCollection 2023.
6
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH).考虑将生理为基础的建模用于肝脏疾病:从非酒精性脂肪肝(NAFL)到非酒精性脂肪性肝炎(NASH)。
Clin Pharmacol Ther. 2023 Feb;113(2):275-297. doi: 10.1002/cpt.2614. Epub 2022 Jun 2.
7
Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy.肝硬化患者脾切除术后临床诊断为门静脉系统血栓形成的血液流变学改变。
Med Sci Monit. 2021 Jun 13;27:e931157. doi: 10.12659/MSM.931157.
8
Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies.肝缺血再灌注损伤中的血液流变学和微循环因素:病理生理学、分子机制和保护策略的最新进展。
Int J Mol Sci. 2021 Feb 13;22(4):1864. doi: 10.3390/ijms22041864.
9
Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.临床诊断为慢性肝病患者的血液流变学改变
J Korean Med Sci. 2016 Dec;31(12):1943-1948. doi: 10.3346/jkms.2016.31.12.1943.
10
A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.一种半机械论模型,用于预测肝硬化对药物清除率的影响。
Clin Pharmacokinet. 2010 Mar;49(3):189-206. doi: 10.2165/11318160-000000000-00000.